Published in Am J Respir Crit Care Med on March 09, 2006
Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev (2009) 4.55
Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med (2009) 1.71
Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1. J Immunol (2009) 1.16
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis (2012) 1.07
The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation. Cytokine (2008) 1.07
Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes Immun (2012) 1.06
Comparative genomics of Toll-like receptor signalling in five species. BMC Genomics (2009) 1.06
Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia. Mol Immunol (2009) 1.00
Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS One (2010) 0.97
Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use. Sci Signal (2016) 0.95
Near-fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis (2009) 0.91
Sepsis: links between pathogen sensing and organ damage. Curr Pharm Des (2008) 0.90
Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality. PLoS One (2012) 0.90
Racial disparities and sex-based outcomes differences after severe injury. J Am Coll Surg (2012) 0.89
Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury. Am J Respir Cell Mol Biol (2011) 0.86
Retracted Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis. Crit Care (2012) 0.86
Gender-specific issues in traumatic injury and resuscitation: consensus-based recommendations for future research. Acad Emerg Med (2014) 0.86
Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research? Pharmacogenomics J (2009) 0.86
The functional polymorphisms of miR-146a are associated with susceptibility to severe sepsis in the Chinese population. Mediators Inflamm (2014) 0.82
IRAK1-dependent signaling mediates mortality in polymicrobial sepsis. Inflammation (2013) 0.81
Cellular mosaicism for X-linked polymorphisms and IRAK1 expression presents a distinct phenotype and improves survival following sepsis. J Leukoc Biol (2013) 0.81
Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. Hum Genet (2008) 0.80
Toll-like receptor genetic variants are associated with Gram-negative infections in VLBW infants. J Perinatol (2013) 0.80
Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia. Genes Immun (2014) 0.80
Genetic variation in the TNF receptor-associated factor 6 gene is associated with susceptibility to sepsis-induced acute lung injury. J Transl Med (2012) 0.79
X chromosome-linked IRAK-1 polymorphism is a strong predictor of multiple organ failure and mortality postinjury. Ann Surg (2014) 0.79
Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-κB activity through promoting TRAF6 ubiquitination. J Biol Chem (2014) 0.78
Reduced oxidative tissue damage during endotoxemia in IRAK-1 deficient mice. Mol Immunol (2012) 0.77
Genetic polymorphisms and posttraumatic complications. Comp Funct Genomics (2011) 0.77
In gender-based outcomes, sex hormones may be important but it is in the genes*. Crit Care Med (2014) 0.76
Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and septic shock in a Chinese Han population. World J Emerg Med (2015) 0.76
Association of REL polymorphisms and outcome of patients with septic shock. Ann Intensive Care (2016) 0.75
The negative regulators of the host immune response: an unexplored pathway in preterm birth. Am J Obstet Gynecol (2009) 0.75
Therapeutic options for pulmonary edema associated with nuclear factor-kappaB activation in septicemia. Am J Respir Crit Care Med (2006) 0.75
Association of genetic variants in the IRAK-4 gene with susceptibility to severe sepsis. World J Emerg Med (2012) 0.75
THP-1-derived macrophages render lung epithelial cells hypo-responsive to Legionella pneumophila - a systems biology study. Sci Rep (2017) 0.75
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med (1994) 27.68
The acute respiratory distress syndrome. N Engl J Med (2000) 25.38
The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol (1996) 22.30
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev (1995) 9.31
Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science (1995) 8.75
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev (1995) 7.36
IRAK-M is a negative regulator of Toll-like receptor signaling. Cell (2002) 6.79
Pathogenetic mechanisms of septic shock. N Engl J Med (1993) 6.64
Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol (2002) 5.48
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol (1995) 5.32
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24
The acute respiratory distress syndrome. N Engl J Med (1995) 5.24
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature (2002) 4.81
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A (1995) 4.16
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature (2002) 4.15
The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003) 4.14
Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med (2002) 4.00
IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A (2002) 3.60
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA (1999) 3.51
NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol (1993) 3.27
Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell (2003) 3.03
Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol (1995) 2.89
Gender differences in human sepsis. Arch Surg (1998) 2.84
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 2.81
Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem (2001) 2.78
Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2000) 2.58
Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996). Crit Care Med (2002) 2.52
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity. Mol Cell Biol (1995) 2.12
Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J Immunol (1999) 2.11
High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis (1992) 2.05
Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med (1994) 2.00
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol (1996) 1.96
IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J Immunol (2000) 1.82
Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha. J Biol Chem (1996) 1.78
Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med (2000) 1.75
IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression. J Biol Chem (2004) 1.65
Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol (2001) 1.58
Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun (2000) 1.58
Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med (1996) 1.55
Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest (1999) 1.54
In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol (1997) 1.47
Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem (2002) 1.45
NF-kappaB activation. Crit Care Med (2000) 1.41
Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med (2003) 1.27
IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability. J Biol Chem (2001) 1.14
Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med (1996) 1.13
NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock (2000) 1.11
Biological variation in the development of sepsis after surgery or trauma. Lancet (1993) 1.04
IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection. Microbes Infect (2004) 0.93
Gram-negative bacterial sepsis and sepsis syndrome. Surg Clin North Am (1994) 0.91
Translocation of the interleukin-1 receptor-associated kinase-1 (IRAK-1) into the nucleus. FEBS Lett (2000) 0.89
Association of a haplotype (196Phe/532Ser) in the interleukin-1-receptor-associated kinase (IRAK1) gene with low radial bone mineral density in two independent populations. J Bone Miner Res (2003) 0.87
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem (2003) 8.34
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med (2004) 5.23
High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol (2005) 5.04
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med (2010) 4.71
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
Transfusion-related acute lung injury: definition and review. Crit Care Med (2005) 3.98
Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med (2005) 3.97
Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44
Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol (2005) 3.38
Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol (2010) 3.22
Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med (2004) 3.19
Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol (2004) 2.89
HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol (2008) 2.80
miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci U S A (2009) 2.74
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64
Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol (2003) 2.50
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A (2005) 2.46
Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol (2008) 2.38
HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol (2005) 2.21
Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest (2011) 2.19
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 2.15
Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med (2004) 2.12
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood (2004) 1.95
Sepsis. Am J Med (2007) 1.93
Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol (2006) 1.88
Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med (2006) 1.82
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med (2004) 1.80
Effectiveness of medical resident education in mechanical ventilation. Am J Respir Crit Care Med (2002) 1.79
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med (2005) 1.77
Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am J Respir Crit Care Med (2009) 1.77
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med (2005) 1.77
Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76
HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. Am J Physiol Cell Physiol (2010) 1.75
Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Am J Respir Crit Care Med (2008) 1.73
Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol (2011) 1.70
Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD (2011) 1.66
Minimizing attrition in a long-term clinical trial of pediatric asthma. Ann Allergy Asthma Immunol (2003) 1.66
HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock (2009) 1.64
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
Beta-adrenergic agonist therapy as a potential treatment for acute lung injury. Am J Respir Crit Care Med (2006) 1.63
Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets (2006) 1.63
Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med (2008) 1.62
Participation of the urokinase receptor in neutrophil efferocytosis. Blood (2009) 1.62
Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med (2008) 1.62
Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med (2008) 1.61
A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. Chest (2005) 1.57
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. Crit Care Med (2003) 1.53
Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem (2010) 1.52
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
The decline and fate of an iron-induced subarctic phytoplankton bloom. Nature (2004) 1.50
Genetic polymorphisms and sepsis. Shock (2005) 1.50
Differences in sepsis treatment and outcomes between public and private hospitals in Brazil: a multicenter observational study. PLoS One (2013) 1.49
The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med (2014) 1.49
MicroRNAs in immune response and macrophage polarization. Arterioscler Thromb Vasc Biol (2013) 1.48
Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol (2004) 1.48
ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation. Crit Care Med (2007) 1.46
High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol (2008) 1.45
Persistently high perinatal transmission of HIV: assessment of risk factors. Pediatr Infect Dis J (2014) 1.44
Participation of miR-200 in pulmonary fibrosis. Am J Pathol (2011) 1.43
Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit Care Med (2006) 1.42
Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol (2012) 1.41
Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activity. FASEB J (2008) 1.39
North American Summit on Aspiration in the Critically Ill Patient: consensus statement. JPEN J Parenter Enteral Nutr (2002) 1.37
Brazilian recommendations of mechanical ventilation 2013. Part I. Rev Bras Ter Intensiva (2014) 1.35
Importance of the personal endotoxin cloud in school-age children with asthma. J Allergy Clin Immunol (2005) 1.33
Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med (2005) 1.33
Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg (2006) 1.30
miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol (2012) 1.29
Automatic versus manual pressure support reduction in the weaning of post-operative patients: a randomised controlled trial. Crit Care (2009) 1.29
The last 100 years of sepsis. Am J Respir Crit Care Med (2005) 1.27
PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci U S A (2008) 1.27
Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med (2003) 1.27
p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. J Immunol (2009) 1.27
Involvement of vitronectin in lipopolysaccaride-induced acute lung injury. J Immunol (2007) 1.26
MicroRNA let-7c regulates macrophage polarization. J Immunol (2013) 1.23
Intensive insulin therapy in critical illness. Am J Respir Crit Care Med (2005) 1.23
Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol (2004) 1.21
Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl Res (2007) 1.21
Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production. Am J Physiol Cell Physiol (2008) 1.18
AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils. FASEB J (2011) 1.17
Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol (2008) 1.17
HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol (2013) 1.17
Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol (2007) 1.16
Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol (2009) 1.16
Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol (2008) 1.15
miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J (2013) 1.15